Literature DB >> 6541042

Effects of calmodulin antagonists on human ovarian cancer cell proliferation in vitro.

Y Kikuchi, I Iwano, K Kato.   

Abstract

Examined were effects of calmodulin antagonists (W-5 and W-7) on proliferation of two kinds of human cell lines, designated HR and KF, derived from serous cystadecarcinoma of the ovary. Although both W-5 and W-7 inhibited their cell proliferation in vitro, the degree of inhibition was more marked with W-5 rather than with W-7. HR cells had higher sensitivity to cisplatinum than KF cells, while KF cells had higher sensitivity to adriamycin. Combinations of calmodulin antagonists and anti-cancer drugs resulted in adjuvant effects with regard to the inhibition of their cell proliferation in vitro.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6541042     DOI: 10.1016/0006-291x(84)90425-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Monitoring by alpha-hydroxybutyrate dehydrogenase of human ovarian carcinoma grown in nude mice.

Authors:  Y Kikuchi; M Miyauchi; K Oomori; I Kizawa; T Kita; K Seki; K Kato
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

Review 2.  Preclinical studies of antitumor prostaglandins by using human ovarian cancer cells.

Authors:  Y Kikuchi; T Kita; J Hirata; M Fukushima
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

3.  Effects of opioid peptides on the cellular immunity in spleen cells from intact nude mice or nude mice bearing human ovarian carcinoma.

Authors:  Y Kikuchi; T Kita; I Nagata
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

4.  Modulation of c-fms proto-oncogene in an ovarian carcinoma cell line by a hammerhead ribozyme.

Authors:  Y Yokoyama; S Morishita; Y Takahashi; M Hashimoto; T Tamaya
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells.

Authors:  H Nakata; Y Kikuchi; T Tode; J Hirata; T Kita; K Ishii; K Kudoh; I Nagata; N Shinomiya
Journal:  Jpn J Cancer Res       Date:  1998-07

6.  Growth-inhibitory effects of N,N-diethyl-2-[4-(phenylmethyl)phenoxy]-ethanamine-HCl combined with cisplatin on human ovarian cancer cells inoculated into nude mice.

Authors:  H Hiramatsu; Y Kikuchi; K Kudoh; T Kita; T Tode; I Nagata
Journal:  Jpn J Cancer Res       Date:  1997-10

7.  Direct intratumoral gene transfer of the herpes simplex virus thymidine kinase gene with DNA-liposome complexes: growth inhibition of tumors and lack of localization in normal tissues.

Authors:  K Takakuwa; K Fujita; A Kikuchi; S Sugaya; T Yahata; H Aida; T Kurabayashi; I Hasegawa; K Tanaka
Journal:  Jpn J Cancer Res       Date:  1997-02

8.  Integrative microRNA and gene expression analysis identifies new epigenetically regulated microRNAs mediating taxane resistance in ovarian cancer.

Authors:  Mohamed K Hassan; Amr A Waly; Waheba Elsayed; Sarah Keshk; Walaa Ramadan Allam; Sherif F El-Khamisy
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

9.  The mechanism of acquired resistance to cisplatin by a human ovarian cancer cell line.

Authors:  Y Kikuchi; I Iwano; M Miyauchi; T Kita; K Oomori; I Kizawa; M Sugita; Y Tenjin
Journal:  Jpn J Cancer Res       Date:  1988-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.